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Summary 
Engagement of the T  cell receptor (TCR) of mature T  lymphocytes can lead either to activa- 
tion/prohferation responses or programmed cell death. To understand the molecular regulation 
of these two fundamentally different outcomes of TCR signaling,  we investigated the partici- 
pation of various components of the TCR--CD3 complex. We found that the TCR-~ chain, 
while not absolutely required, was  especially effective at promoting mature T  cell apoptosis 
compared with the CD3e, y, or ~ chains. We also carried out mutagenesis to address  the role 
of the immunoreceptor tyrosine-based activation moti~ (ITAMs) that are the principal signal- 
ing components found three times in the TCR-~ chain and once in each of the CD3e, ~, or 8 
chains. We found that the ability of the TCR-~ chain to promote apoptosis results both from a 
quantitative effect of  the presence of  multiple ITAMs as well as qualitatively different contribu- 
tions made by individual ITAMs. Apoptosis induced by single chain chimeras revealed that the 
first ~ ITAM stimulated greater apoptosis than the third ~ ITAM, and the second ~ ITAM was 
unable to trigger apoptosis. Because microheterogeneity in the amino acid sequence of the var- 
ious ITAM motifi found in the TCR-~ and CD3 chains predicts interactions with distinct src- 
homology-2-domain signaling proteins, our results suggest the possibility that individual ITAM 
motit~ might play unique roles in TCR responses by engaging specific signaling pathways. 
F 
~rogrammed cell death  (PCD) 1 or apoptosis is  a regu- 
lated process by which multicellular organisms  elimi- 
nate unneeded or harmful cells  (1, 2).  In the immune sys- 
tem apoptosis of lymphocytes that is triggered by antigen 
receptors, i.e.,  Ig on B  lymphocytes and the TCR  on T 
lymphocytes, is  crucial for the  establishment of the lym- 
phocyte repertoire and the clonal regulation of  immune re- 
sponses (3-5). Apoptosis caused by TCR signals can occur 
at two  different points  in  the  life of a  T  cell.  Apoptotic 
death  occurs  first  during  differentiation  in  the  thymus 
where strong TCIL engagement may lead to negative se- 
lection, which is  an important means  of establishing self- 
tolerance through the elimination of cells with autoreactive 
TCRs  (6-8).  TCR-induced  apoptosis  may later  befall  a 
fully mature  T  cell if strong  TCR  reengagement occurs 
when the cell is activated and proliferating (9-11). Mature 
T  cell death plays a critical role in peripheral immune ho- 
1Abbreviations used in this paper: ITAM, immunoreceptor  tyrosine-based 
activation motifi PCC, pigeon cytochrome  C; PCD, programmed cell 
death; PI, propidium  iodide; SH2, src-homology-2. 
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meostasis  and tolerance (5).  Evidence would  suggest  that 
the  molecular mechanisms  of TCR-induced  apoptosis  in 
developing thymocytes are not the same as those in mature, 
peripheral T cells (12). 
Involvement  of the  TCR  in  both  the  activation  and 
death of mature  T  cells  raises  the  interesting question  of 
how these  different outcomes are  regulated.  The  TCR- 
CD3  complex  is  an  ohgomeric  structure,  composed  of 
multiple chains (TCR-o#I3 or -~//8 associated with CD38, 
~/, e, and ~ or "q). Antigen recognition is accomplished by 
the polymorphic TCtL-a/[3  (or -~//~)  heterodimers. The 
invariant CD3 proteins (~//e, 8/e dimers) and the ~/'q pro- 
teins  (~/~,  ~/'q  dimers)  promote efficient cell surface ex- 
pression and transduce TCR signals  (13, 14).  Signaling re- 
quires  a  conserved  18-amino  acid  sequence,  termed  the 
immunoreceptor tyrosine-based activation motif (ITAM), 
which is found three times in the TCR-~ chain and once 
in each of the  CD3  subunits  (%  ~,  and e)  (15-17).  Each 
ITAM contains a pair of tyrosine-X-X leucine/isoleucine 
(Y-X-X-L/I) motif, that are separated by 10/11 amino ac- 
ids  (17).  The tyrosine residues in  each ITAM are rapidly 
phosphorylated after TCR  ligation  and  serve as  docking 
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rosine residues by src-homology-2  (SH2) domains (18-24). 
Deletions  of  the  ITAM  or  mutations  of  the  tyrosines 
within the Y-X-X-I/L motifs cause a loss of function indi- 
cating their vital role in TCR  signaling  (25-27).  There  is 
heterogeneity in the amino acids adjacent to the phospho- 
tyrosines  in  the  various  ITAMs found in  the  ~  and  CD3 
chains  (see  Table  1).  Experiments  by Songyang et al.  (22, 
23) show that these amino acids determine the specificity of 
binding of SH2  domains,  suggesting that individual TCR 
ITAMs could couple to distinct SH2 domain signaling pro- 
teins (22, 23). We therefore explored the idea that distinct 
chains and/or ITAMs of the oligomeric TCR-CD3  com- 
plex  could  have  an  especially  important  role  in  initiating 
apoptosis. 
Studies of chimeras between the extracellular domain of 
non-TCR proteins, such as IL-2Rci (Tac) or CD8, and the 
intracytoplasmic  portions  of the  TCR-CD3  chains  have 
revealed that the  cytoplasmic tail of the TCR-~  or CD3e 
can couple external signals to both proximal  (induction  of 
tyrosine  phosphoproteins,  Ca  2+  and  inositol  phosphates) 
and distal  (IL-2 secretion, CD69 expression)  signaling func- 
tions  (26-31).  Chimeric  molecules  containing  either  the 
CD3e or TCR-~  cytoplasmic domains  are also capable  of 
mediating  thymocyte maturation,  proliferation,  and selec- 
tion  (32).  Therefore,  the view has emerged that there  are 
two independent signaling modules with overlapping func- 
tions for activation: one mediated by the TCR-~ chain and 
one mediated by the CD3 chains, especially CD3e (33, 34). 
Recent  analyses of cytotoxic T  cells  have  shown that the 
TCR-~ cytoplasmic domain can upregulate Fas-dependent 
cytolysis of target cells,  but the  CD3e chain has not been 
examined  in this  regard  (35).  To what extent  there  is re- 
dundancy in signal pathways for autoregulatory mature  T 
cell  apoptosis  has  not  been  investigated.  We  therefore 
tested the role of the TCR-~ or CD3e, %  or 8  chains and 
their ITAM motifs in single chain chimeras and in the con- 
text of a complete receptor for the ability to induce mature 
T  cell apoptosis. 
Materials and Methods 
Constructs.  Chimeric  proteins  containing  the  external  and 
transmembrane portions of the Tac protein associated with cyto- 
plasmic  portions of either ~, %  8, or e were prepared as previ- 
ously described  (29,  36,  37).  Briefly,  DNA segments  encoding 
the relevant  portions of the CD3 chains were obtained by PCR, 
cloned into pCDL SR(x (36, 37), and verified by DNA sequence 
analysis. The sequences  of  DNA primers used were the following: 
5' CCA TAT TTA CAA CAG ATC TCC AGG 3' present in 
Tac transmembrane domain and 5' GTC CAA ACT ACT CAT 
3' present in PCDL SRcx vector. DNA segments  encoding for 
mutated tyrosines  of the ~ cytoplasmic chain into phenylalanine 
were  obtained by PCR  using  two  sets of overlapping primers 
containing a point mutation as follows: first ITAM of the ~ chain 
(Y72, Y83 mutated into F), 3' primer [5' GAG CTC AAT CTA 
GGG CGA AGA GAG GAA TTT GAC GTC TTG], 5' primer 
[5' CTT CGC CCT AGA TTG AGC TCA TTG AAG AGC 
TGG TTG]; second ITAM of the { chain 0/111 and Y123 mu- 
tated into F),  3' primer [5' GCA GAA AGA CAA GAT GGC 
AGA AGC CTT CAG TGA GAT C], 5' primer [5' CTT CTG 
CCA TCT TGT CTT TCT GCA GTG CAT TGA ATA CGC 
CTT]; and third ITAM of the ~ chain 0/143, Y153 mutated into 
F), 3' primer [5' CTC AGC ACT GCC ACC AAG GAC ACC 
TTT GAT GCC CTG], 5' primer [5' GTG TCC TTG GTG 
GCA GTG CTG AGA CCC TGG AAA AGG CCA TC]. Zle, 
Z2r  Z3e, GET, and DET are five chimeric molecules containing 
Tac extracellular  and transmembrane domains and the full CD3e 
cytoplasmic domain in which the e ITAM has been replaced by 
either the TCR-~ ITAM 1, TCR-~ ITAM 2, TCR-~ ITAM 3, 
CD3% or CD38 ITAM, respectively,  by using two sets of over- 
lapping primers  as follows:  ZIG 3' primer [5'-GGG CGA AGA 
GAG GAA TAT GAC GTC TTG AAT CAG AGA GCA G], 
5'  primer  [5'-CCT CTC  TTC  GCC  CTA GAT TGA  GCT 
CAT TGT AGT CTG GGG TTG G]; Z2{ 3' primer [5'-GAC 
AAG ATG GCA GAA GCC TAC AGT GAG ATC AAT CAG 
AGA GCA G}, 5' primer [5'-CTG CCA TCT TGT CTT TCT 
GCA  GTG  CAT  TGT  AGT  CTG  GGT  TGG  G];  Z3{  3' 
primer [5'-GTG CCA GTG CTG AGA CCC TGA TAG TCT 
GGG],  5' primer [5]-CAG CAC TGC CAC CCA GGA CAC 
CTA TGA TGC CTG AAT CAG AG]; GET  3'  primer  [5'- 
CCG GGA ATA TGA CCA GTA CAG CCA TCT CAA TCA 
GAG AGC AG],  5'  primer  [5'-TCA TAT TCC  CGG TCC 
TTG AGG GGC TGG TAG TCT GGG TTG GG] ; and DET 
3'  primer  [5'-CGT GAA GAT ACC CAG TAC AGC CGT 
CTT A.AT CAG AGA GCA], 5' primers  [5'-GGG TAT CTT 
CAC  GAT  CTC  GAA  GAG  GCT  GAT  AGT  CTG  GGT 
TGG].  The  TCR-~,  CD3e,  CD3"/,  and  CD38  ITAM  amino 
acid sequences  used are shown in Table  1. CD3 chimeras  were 
necessary  because Tac fusion proteins  containing the full  cyto- 
plasmic  portions of the CD37 or CD38 chains  are unstable  and 
have very poor surface  expression  (29). The single letter amino 
acid code is: A, Ala; C, Cys; D, Asp; E, Glu; F, Phe; G, Gly; H, 
His; I, Ile; K, Lys; L, Leu; M, Met; N, Ash; P, Pro; Q, Gln; R, 
Arg; S, Ser; T, Thr; V, Val; W, Trp; Y, Tyr. 
Cell Culture.  Tac clones  were cells expressing  chimeric pro- 
teins comprised of the Tac extracellular  and transmembrane fused 
to the intracytoplasmic portion of  the TCR-{ chain (termed TT-0 
or the CD3e chain (termed TT-e). The clones TT-~4 and TT-e5 
were a gift from Dr. R.D.  Klausner  (National Cancer Institute, 
Bethesda,  MD). For new clones, constructs were stably expressed 
in BW5147(ot-[3-)  (BW),  a variant of the mouse BW cell line 
that synthesizes no or, [3, g, or ~/chains  (29). BW cells were trans- 
fected by electroporation  with  18  Ixg of plasmid  linearized  by 
HindlII and 2  I.tg of pGEMneo  cut by EcoRI per  107  cells. A 
voltage of 350 V and a capacitance  of 1,300/xF were applied  by 
an electroporation unit (BTX, San Diego, CA). Stable  transfec- 
tants were selected with 1.5 mg/ml ofgeneticin (G148)  (GIBCO 
BRL, Gaithersburg,  MD). Clones were obtained by limiting di- 
lution according to the Poisson distribution.  Intensity of Tac ex- 
pression  on the cell surface was determined by flow cytometry. 
Table 1.  Sequences  of Mouse TCR-CD3 ITAM 
TCR-{I  Q LYNELN  L G R R E - _YD  VL 
TCR-~2  GV_YNALQKDMAEAYSEI 
TCR-~3  GLYQGLSTAT  KDTY_DAL 
CD3~  QLYQPLKDREYDQY_SHL 
CD3{  PDYEPIRKG  QRDLYS  GL 
CD38  QLY_QPLRDR  E D T QYS RL_ 
2110  TCR-~ Chain Facilitates Mature T Cell Death For transgenic  mouse studies, lymph node T  cells were obtained 
from 4 -/- mice with a full-length ~ transgene  (~-/-:Tg~) or 4  -/- 
mice with a transgene  expressing  a truncated ~ molecule lacking 
the cytoplasmic domain (amino acids 67-150)  (4-/-: Tg~A67-150 
(38, 39). The cells were stimulated  first for 48 h with 30 ng/ml of 
phorbol dibutyrate (PDB; Sigma  Chemical Co., St. Louis,  MO) 
and 1 Ixm/rnl of ionomycin (Calbiochem-Novabiochem Corp., 
San Diego, CA), washed, and then stimulated  with 50 IU/ml of 
human recombinant IL-2 (Proleukin;  Cetus  Corp., Emeryville, 
CA) for an additional 48 h as previously described (9, 40). Prolif- 
eration  assays, culture  supernatant  collection,  and  apoptosis  in- 
duction assays were then performed. 
Apoptosis Induction Assay.  Cells  (5  X  104) were  cultured  in 
triplicate  in 96-well flat bottom plates in a final volume of 200 ~1. 
Anti-Tac (gift from Dr. Thomas Waldmann, National Cancer In- 
stitute,  Bethesda,  MD) or anti-CD3 (145-2Cll)  (41) stimulation 
was performed using plates precoated at 37~  for 16 h with vari- 
ous concentrations ofmAb dissolved in 100 btl of PBS. It is note- 
worthy that the anti-Tac mAb used in these  studies  (42) appears 
to  be  a  weaker  agonist  than  the  commercially available  mAb 
(33B3.1)  used in previous studies  of Tac-TCR subunit chimeras 
(29). After 24 h of incubation of the cells at 37~  100 ~1 super- 
natant was harvested for IL-2 assay and the number of viable cells 
was measured  cytofluorometrically (43).  Briefly,  cells were  re- 
moved from culture wells by vigorous pipetting, washed once in 
PBS,  and  resuspended  in  a  constant  volume  of FACS  |  buffer 
(PBS 1%, BSA 0.05%,  sodium azide)  and propidium iodide (PI; 
20 I~g/ml). Each sample was prepared in duplicate.  Samples were 
analyzed on a FACScan  |  II instrument (Becton Dickinson & Co., 
Mountainview, CA) for a constant period of time (instead of col- 
lecting a constant number of events,  without live  gating).  The 
number of viable  cells per period of collection was gated by for- 
ward scatter profile and PI exclusion.  The percentage of loss was 
calculated  as 100  ￿  [1-(number of viable  cells receiving Ab or 
TCtL stimulation/number of viable cells without any treatment)]. 
For antigen stimulation experiments,  2B4.11  and a derivative  cell 
line  MA  ~A66-157  (gifts from Dr.  Bernard  Malissen,  Inserm- 
CNtLS, Marseille-Luminy, France) were used (33, 34, 44). Sam- 
ples  containing  5  5<  10  4  cells were  incubated  with  irradiated 
(3,000  rad) H-2E  k splenocytes (5  ￿  10  s) from B10.A mice, and 
various  concentrations of pigeon cytochrome C  peptide  81-104 
(PCC p81-104) in a final volume of 200 ~1. After 24 h of incuba- 
tion at 37~  100 ~1 ofsupernatant was harvested for the IL-2 as- 
say and the level ofT cell death was quantitated as described pre- 
viously (5,  11,  40,  43).  Cell surface  expression  of the  chimeric 
proteins was detected by staining with an appropriate dilution of 
PE-conjugated anti-CD25 (PharMingen,  San Diego, CA) for 20 
min  followed by  analysis using  a  FACScan  |  II  analyzer  with 
CellQuest  TM  software  (Becton Dickinson & Co.). 
IL-2 Assay.  IL-2  was  detected  by  ELISA using  Abs  pur- 
chased from PharMingen,  essentially  as  per  manufacturer's  in- 
strnctions.  Data are  expressed  as IL-2 U/m/, calculated  by com- 
parison with standard  curve determined with recombinant mouse 
IL-2 (PharMingen). 
Analysis of DNA Fragmentation.  Fragmentation of the genomic 
DNA isolated from cells cultured on plate-bound anti-Tac mAb was 
analyzed by agarose gel electrophoresis as previously described  (40). 
Results  and Discussion 
The Tac-r  Chimeric Protein Can Induce Programmed T  Cell 
Death.  We  first  studied  apoptosis  induction  using  two 
clones, TT-~4 and TT-~7  (29),  that express chimeric pro- 
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teins  containing the  extracellular  and  transmembrane  do- 
mains from CD25 (Tac) and the cytoplasmic domain of the 
TCR-~  chain.  Biochemical  analyses  indicated  that  these 
chimeric molecules do not associate with endogenous CD3 
subunits and therefore act as physically independent signal- 
ing molecules  (32).  When we  cross-linked the  TT-~  chi- 
meric molecule, we detected  dramatic  induction of apop- 
tosis as indicated by the microscopic appearance of the cells 
and the  electrophoretic  pattern  of cleaved genomic DNA 
(Fig.  1, A  and B). The TT-~4 and TT-~7 clones had a sim- 
ilar surface expression of Tac chimeric molecules (analyzed 
cytofluorometrically, data not shown) and showed the same 
dose-response  for  apoptosis  as  measured  by PI  inclusion 
(Fig.  1  C).  The BW parental  cell hne  did  not  die  at  any 
dose of anti-Tac  tested  (Fig.  1  C).  BW cells were not in- 
nately resistant to death because phorbol ester and ionomy- 
cin caused the death of BW cells  equivalent to the TT-~4 
and  TT-~7  clones  (Fig.  2  C).  These  initial  results  con- 
firmed and extended the observations ofVignaux et al.  (35) 
who found that TCR-~  chain could induce Fas ligand on 
cytolytic T  cells  at levels sufficient to kill target  cells.  We 
also found that TCR-~  chain signals induced Fas and Fas- 
ligand mRNA  (data not shown).  However, in our model, 
TCR-~  signaling  was  associated  with  apoptosis  of the  T 
cells themselves,  similar to autoregulatory T  cell apoptosis, 
which plays an important role in peripheral tolerance (45). 
TCR-CD3~  Subunits  Lacking  the  Cytoplasmic  Domain 
Failed to E~ciently Induce T  Cell Apoptosis.  We  next  eval- 
uated the role of the TCR-~ chain in mature T  cell death 
by analyzing the  MA5.8  cell line,  which  is  a  mutant  de- 
rived from the 2B4.11 hybridoma that synthesizes all of the 
TCR  components except the TCR  ~/'q proteins and there- 
fore has no surface expression of the TCR  (29,  44).  TCR 
surface expression can be restored by expression constructs 
for the TCR-~ chain either with or without a cytoplasmic 
domain  (33,  34,  44).  We compared a MA5.8 transfectant, 
MA ~A66-157,  that  lacked  almost  the  entire  cytoplasmic 
portion  of the  TCR-~  chain,  including  all  three  ITAMs 
(amino acids 66-157), to parental 2B4 cells that expressed a 
full-length ~ chain. This allowed us to evaluate the impor- 
tance  of TCR-~  chain  signaling  in  mature  T  cell  death 
within the context of the oligomeric TCR  complex. 
After stimulation with immobilized anti-CD3e mAb, we 
found  that  apoptosis  was  substantially  less  for the  MA5.8 
cells  lacking  the  intracytoplasmic  domain  of ~  (Table  2), 
compared with 2B4 cells.  Similar results were obtained af- 
ter  stimulation  of the  hybridomas  with  the  physiological 
PCC  peptide  ligand  (Table  2).  Although peptide  stimula- 
tion caused less overall death than cross-linking Ab, the ab- 
sence  of the  TCR-~  cytoplasmic  signaling  domain  was 
associated with a  5-10-fold reduction in the level of anti- 
gen-induced  apoptosis.  These  observations  contrast  with 
previous work showing that IL-2 can be highly induced by 
a TCR  complex that lacks the  cytoplasmic portion of the 
TCR-~ chain (29, 33, 34). Our results reveal that apoptosis 
in these  T  cell hybridomas is most efficiently triggered by 
TCR  complexes  that  have  an  intact  TCR-~  cytoplasmic 
signaling domain. Figure 1.  Chimeric  proteins bearing the cytoplasmic  domain of TCR,-~ chain cause autoregulatory  T cell apoptosis. (A) Photomicrographs  of trypan 
blue stained-cells after treatment with plate-bound anti-Tac mAb (10 ~g/ml) for 24 h. Dead cells are darkly stained and viable cells are unstained. (B) 
Agarose gel electrophoresis of  DNA isolated from cells stimulated with anti-Tac mAb. (MW) 123-bp ladder DNA molecular  weight marker. Samples for 
lanes 1 and 2 are from BW cells and lanes 3 and 4 are from TT-~4 cells. (C) TT-~4 and TT-~7 clones were exposed to 1, 3, or 10 I~g/ml ofinunobilized 
anti-Tac mAb for 24 h as indicated. The anti-Tac mAb used in these experiments is a weaker agonist than the commercial  anti-Tac mAb (33B3.1) used 
in previous reports (29), and therefore had to be used in greater concentrations. Quantitation of  cell loss was determined by flow cytometric analysis using 
PI as described in Materials and Methods. Control samples were stimulated by PMA (10 ~g/ml) and ionomycin (1 I.LM). 
Peripheral Lymph Node T  Cells Require the  TCR-~ Cyto- 
plasmic Domain  for Ej~cient TCR-mediated Apoptosis.  We 
next verified the requirement for the ~ signaling domain in 
the induction of apoptosis  of nontransformed lymph node 
T  cells.  We  used  mice that  were  homozygously deficient 
for the TCR-~  gene as well as offspring that had been re- 
constituted with either full-length TC1L-~ or the ~A67-150 
derivative  which contains  no  ITAM signalling motit~  (38, 
39).  A  previous investigation of these  mice found that the 
cytoplasmic signaling portion of the TCR-~  modestly im- 
proved thymocyte maturation, but was not obligatory (39). 
We therefore harvested peripheral lymph node T  cells from 
the  mouse  strains  and  induced  activation  and  cell  cycling 
with IL-2 to predispose the cells  to apoptosis (9).  We con- 
firmed  that  T  cells from the  reconstituted  transgenic  lines 
had  comparable  surface  expression  of TCR,  CD4,  and 
CD8, whereas the ~-/-  mouse had no surface TCR  (38) 
(Fig.  2 A  and data not shown).  TCR  cross-linking at  10 h 
caused substantial  apoptosis in lymph node cells from mice 
reconstituted  with  a  full-length  ~  chain  (~-/-:Tg~),  but 
very litde  in T  cells  expressing a  cytoplasmically deleted 
chain (~-/-:Tg~A67-150) or no ~ chain at all (~-/-)  (Fig. 
2 B). By contrast, we found that peripheral T  cel/s containing 
the Tg~A67-150 chain produced just as much IL-2 at various 
concentrations ofTCR  cross-hnking Ab as T  cells expressing 
the full-length  ~ chain  (Fig.  2  C).  These  results  show that 
under identical stimulation conditions, the signaling portion 
of the  TCR-~  chain  is  dispensable  for activation and IL-2 
production,  but  required  for  apoptosis.  The  effect  of the 
TC1L-~  chain  appeared  to  involve  enhancing  the  rate  of 
apoptosis because prolonged stimulation  of T  cells bearing 
the truncated ~ chain could lead to significant apoptosis (data 
not shown). However, this effect on the efficiency of signal- 
ing appeared to be selective for apoptosis as no difference was 
observed  for activation  events  such  as  IL-2  production  or 
IL-2 receptor expression (Fig. 2  C  and data not shown). 
The ~ Cytoplasmic Domain Promotes T Cell Apoptosis More 
Effectively than the  Signaling Domains of the  CD3e  Chain. 
To further assess the function of the TCR-~ chain in ma- 
ture  T  cell  apoptosis,  we  directly compared  the  signaling 




10  o 
~  ;ntrol  ~b~'\':Tg ~  A 
....  150 
101  10  =  10O  104 
CD3-E  expression  (Log) 
[]  ~-\"  B  C 
[]  ~-\-:Tg ~  600 
50  ~  400500~  ￿9  ~\-;Tg~67-150  T  T 
::t  r  ,0] 
0  ,  0~  0  2.5  5  7.5  10  0  1  3  10 
anti-CD3a  (l~g/ml)  anti-CD3c  (pg/ml) 
Figure 2.  Mature lymph node T lymphocytes  require  the TCR-~ cy- 
toplasmic  domain  for  efficient TCR-mediated apoptosis in  transgenic 
mice. Peripheral lymph node  cells from ~-/-,  ~-/-:Tg~ (wild-type 
T Ctk-~ chain) and ~-/-:Tg~A67-150 (deletion of TCR-~ ITAMs from 
amino acids 67-150) were activated by 30 ng/ml PDB (phorbol 12, 13 
dibutyrate) and 1 Ixg/ml ionomycin, stimulated with 50 IU/ml human 
IL-2 and then  rechallenged with various amounts of plate-bound anti- 
CD3e as indicated. (A) Flow cytometry histogram of CD3e expression on 
activated and cycling lymph node cells from the transgenic mice with a 
full-length or deleted TCR-~ chain. Control represents unstained cells. 
(B) Stimulation of activated cells (~-/-, crossed square, ~-/-:Tg~: open 
square and ~--/-,Tg~A67-150, solid square) was carried out with different 
concentrations of immobihzed anti-CD3e  mAb (145.2Cll) for 10 h as 
indicated. The percent cell loss was calculated by PI exclusion via FACS  | 
(C)  IL-2  production  for  various cell populations was  determined  by 
ELISA on supematant collected at 10 h after anti-CD3 stimulation. The 
IL-2 units were calculated by comparison with a standard curve using re- 
combinant mouse IL-2. 
domains of the CD3  chain to that of the TCR-~  chain us- 
ing single  chain  chimeras.  We prepared stably transfected 
BW cells expressing a Tac chimeric protein containing the 
cytoplasmic portion  of the  CD3e  chain  that  harbors  one 
ITAM  motif (TT-e)  and  then  selected  TT-e  and  TT-~ 
transfectants that had comparable surface expression of the 
chimeric proteins (Fig. 3 A). After stimulation with immo- 
bilized anti-Tac mAb for 24 h,  significant T  cell apoptosis 
(manifested by PI uptake and a decrease in the PI-negative 
cells) was  observed for the  TT-~4  clone but very little in 
the  TT-e5  clone  (Fig. 3  B).  A  dose-response comparison 
showed  that  between  1  and  3  p,g/ml  of anti-Tac  mAb, 
greater PCD  was  observed with  the TT-~4  clones  (maxi- 
mum 80% cell loss) than with the TT-e5 clones (maximum 
35%  cell loss)  (Fig. 3  C).  Table  3  shows  several indepen- 
dent TT-~ clones prepared in our laboratory with different 
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Table  2.  Anti CD3e Stimulation Fails to Induce PCD without 
the TCR-~ Cytoplasmic Domain 
Percent cell loss 
Control cell fines 
MA ~A66-157  (2B4) 
% 
Anti-CD3e Ab  0.3 Ixg/ml  0  57 
1 Ixg/nal  23  74 
3 p~g/ml  29  78 
10 I~g/ml  30  80 
PCC (81-104)  100 p~M  3  32 
(expt. 1)  10 p,M  7  35 
(expt. 2)  10 p,M  1  ND 
The parental cell line, 2B4.11 or MA ~A66-157, was stimulated with 
immobilized anti-CD3e Ab (2C11.145). For antigen stimulation exper- 
iments, 2B4.11 or MA ~A66-157 cell lines were incubated  (5  ￿  104 
cells) with H-2E  k -  APC (5  ￿  10  s) and the concentrations  of PCC 
p81-104 shown. After 24 h of incubation, the cells were harvested and 
stained with anti-TCR Vet11 to distinguish them from APC and the 
percent cell loss was calculated by FACS  |  analysis. 
levels of Tac  surface expression.  In all cases,  TT-~  clones 
consistently  exhibited  50-80%  cell  loss  whereas  TT-e 
clones  only  underwent  10-35%  cell loss  after  Tac  cross- 
linking. For both TT-~ and TT-e  clones, higher Tac sur- 
face expression was correlated with greater cell loss. These 
results  show  that  both  the  TC1L-~  chain  and  the  CD3e 
chain can transmit signals for T  cell death. However, when 
confronted with an equivalent stimulus, chimeras contain- 
ing the ~ cytoplasmic domain induce apoptosis substantially 
better than chimeras containing the e cytoplasmic domain. 
Efficient  T  Cell Apoptosis Requires the ITAM Motifs  in  the 
TCR-~ Chain.  To develop further insight into the role of 
the TCR-~  chain in apoptosis, we prepared stable transfec- 
tants with mutant single chain chimeras in which phenyla- 
lanine  was  substituted  for  both  tyrosines  in  the  ~  chain 
ITAMs so that the ITAMS were inactivated either individ- 
ually or in pairs (Fig. 4 A). We made the striking observa- 
tion that in any construct in which the membrane proximal 
ITAM (Z1 ITAM) was mutated, the ability to induce apop- 
tosis was lost. The fact that apoptosis was severely impaired 
even  when  the  second  and  third  ~  ITAMs  were  intact 
(construct TTmZ1),  suggested an especially important role 
for  the  Zl  ITAM.  We  also  found  the  membrane-distal 
ITAM  (Z3)  played a  clear  contributory  role  since  muta- 
tions  in  it  always  decreased  the  overall level of apoptosis 
obtained.  The  second  ITAM  (Z2)  had  more  variable ef- 
fects. The TTmZ2  construct revealed that if the Zl and Z3 
ITAMs were intact, apoptosis was not decreased by the loss 
of Z2 ITAM. On the other hand, if the Z3 ITAM was mu- 
tated, alteration of the Z2 ITAM further decreased, but did 
not  abolish,  apoptosis  (compare  the  TTmZ2/3  and  the 
TTmZ3  constructs).  These  results provided evidence that A 






r~/  TT-~4 
ANTI-TAC  mAb  (Log) 
U  3  pg/ml of anti-TAC  10 p,g/ml  of anti-TAC 
500 I TT- E5 )  .  .  _5001.i-r_ e5  I  ~__ unstlmulate(:l /,~lli~  u  nstim  ulate  d 
i  stimulated  stimulated 
O  fJ  500  TT-~4 I  I  500 "Pr- ~4 
~)  /~1  unstimulated  /~  unstimulated 
O 
I  ~  stimulated 




(I)  75% 
O  -I 





TT-~4  ~  T-~5 
~~BW  5147 
0  0.1  0.3  1  3  10 
ANTI-TAC mAb (~g/ml) 
Figure 3.  Stimulation  by plate-bound anti-Tac mAb induces greater cell death of the TT-~4 clone than the TT-e5 clone. (A) Flow cytometry histo- 
grams of the expression  of TT-~ or TT-~ chimera as determined by staining  with PE-labeled  anti-CD25 mAb. The BW cell line is shown as a control. 
The mean  fluorescence  intensity  was 270 for TT-~ clone, 234 for TT-e clone and 7.8 for BW cells. (B) Flow cytometry histograms of TT-~ and TT-c 
clones that were unstimulated  or stimulated  for 24 h with either 3 or 10 p,g/ml ofanti-Tac mAb. The number of viable cells (gate) was determined after 
analysis  by forward scatter profile and PI exclusion.  Cells  with low PI fluorescence  are viable. (C) Cell loss calculated  after 24 h of stimulation  by different 
concentrations  of immobilized  anti-Tac mAb. Samples  were done in duplicate. The percent cell  loss were calculated  as described  in Materials and Methods. 
the ITAM motifs of the ~ chain, particularly the Z1 ITAM, 
were important for apoptosis. The results also suggested the 
interesting possibility that  individual ITAMs  could make 
different contributions to the overall potency of the ~ chain 
in  stimulating apoptosis,  which  might  imply that  each 
ITAM may have a qualitatively distinct role in signaling. 
To more directly demonstrate the different effects of the 
various ITAM motifs in apoptosis, we compared Tac chi- 
meric proteins containing either the full-length ~ cytoplas- 
mic domain, each ~ ITAM in a single copy, or the ITAMs 
derived from the CD3 e,  %  or 8  chains. The single copy 
ITAMs were  all tested in the  context of the  CD3~  cyto- 
plasmic sequences to eliminate effects caused by the flank- 
ing amino acid sequences in each of the TCR  chains. We 
found that greater apoptosis was induced by the full-length 
chain  than  by  any  single  ITAM  construct  (Fig.  4  B). 
Among the single ITAM chimeras, the Z1, i.e., membrane 
proximal ITAM from the ~ chain, caused substantial apop- 
tosis, whereas the Z3 motif and the CD3e ITAMs triggered 
a  very low but reproducible level of apoptosis.  The  Z2, 
CD3% and CD38 ITAMs were incapable of transmitting a 
death signal. In all cases,  stable transfectants that had com- 
parable  surface  expression of the  Tac  chimeric molecules 
were  examined, and control experiments showed  that  all 
transfectants were susceptible to apoptosis induced by PMA 
and ionomycin (data not shown).  These  data support the 
conclusion that the  Z1  ITAM, even when divorced from 
other sequences in the TCI~-~ protein, maintains its ability 
to strongly signal for apoptosis. Moreover, the TCR-~ pro- 
tein has  the  quantitatively strongest effect  in signaling for 
apoptosis by virtue of the  combination of Z1  with  addi- 
tional ITAMs. 
Our  observations point  to  the  recruitment of specific 
ITAM motifs in the transmission of a death signal. Our data 
Table 3.  Anti-Tat Stimulation  Induces Higher Cell Death in TT-~ Clones than in TT-~ Clones 
Percent  Fluorescence  Anti-Tac  Percent  Assay 
Chimera  Clones  Tac  § cells  intensity  mAb  cell loss  length 
%  I.~g/ml  %  h 
TT-~  clone 4  99  47  10  54.3  24 
TT-~  clone 7  98  56  10  51.6  24 
TT-~  clone 4a  98  178  10  79  24 
TT-~  clone D20p  98  288  5  60  20 
TT-e  clone 5  99  50  10  12  24 
TT-e  clone 5. b5  99  95  5  20  20 
TT-e  clone 5  99  159  10  33  24 
TT-e  clone 5. e5  97  203  5  18  20 
Different experiments using clones of TT-~ or TT-e stimulated by various concentrations of anti-Tac mAb as indicated. The percent cell loss were 
calculated as described  in Materials and Methods. 
2114  TCR-~ Chain Facilitates Mature T Cell Death Figure 4.  Tyrosine mutations implicate spe- 
cific ITAM motif~ in  T  cell apoptosis. (Left) 
Structure of chimeric molecules; (Right) Histo- 
grams of the cell loss after Tac cross-linking as 
indicated. The Tac extracellular and transmem- 
brine domain are shown as filled rectangles. (A) 
Mutations in the ITAMs of the TCR-~ chain 
affect apoptosis.  Mutations in each of  the TCR-~ 
ITAMs: Z1, mutations of Y72, Y83 into F; Z2, 
mutations of  Yl11, Y123 into F; and Z3, muta- 
tions of Y143, Y153 into F, were constructed 
either singly or in pairs (shaded boxes). Unmu- 
tated ITAMs (open boxes). Cell loss was calcu- 
lated  by flow  cytometry  after stimulation by 
5 Izg/ml  of immobilized  anti-Tac  mAb  for 
24 h.  (B)  ITAMs  from  the  TCR-~  or  CD3 
chains, when  substituted for the  ITAM of the 
CD3r chain, have different abilities to signal for 
apoptosis. The various ITAMs are shown with 
different shading. Each sample was performed 
in duplicate and analyzed by FACS  | 
suggest a more selective function for different ITAMs than 
can be inferred from previous analyses of the various TCR 
chains  in  triggering  activation  and  IL-2  expression.  Re- 
cently, Songyang et al.  (22,  23)  have provided elegant ex- 
perimental  evidence  that  the  three  amino  acids  that  lie 
immediately adjacent to the carbonyl group ofphosphory- 
lated  tyrosines  serve  as  specificity  determinants  for  the 
docking  of different  SH2  domain  signalling proteins.  In 
light of their observations, it is important to note that these 
key residues  differ between  the  Z1  ITAM  and  the  other 
ITAMs  that  are present in  the  oligomeric TCR  complex 
(Table 1). It may be significant that the Zap70 signaling ki- 
nase associates more strongly with Z1  ITAM than with the 
Z2,  Z3,  or e  ITAMs  (24).  However,  our  data could also 
imply that the signaling pathways engaged by the TCR  to 
promote  apoptosis  differ from  those  involved in  other  T 
cell responses. Further studies will be directed at uncover- 
ing the nature of the signals that initiate activation and apop- 
tosis.  Elucidation  of the  Z1  ITAM  signaling mechanism 
will enhance  our molecular understanding of the proprio- 
cidal apoptosis of mature T  cells that preserves lymphocyte 
homeostasis and peripheral tolerance (5, 40, 45). 
We thank Drs. R.D. Klausner,  L.E. Samelson, and F. Letoumeur for providing TT-~ and TT-e clones, con- 
structs, and advice; and Dr. B. Malissen for providing the MA ~A66-157 cell lines. We thank Drs. Ron Ger- 
main, Stefen Boehme, and Pamela Schwartzberg for helpful discussions and a critical reading of the manu- 
script. 
B. Combadibre was supported by lnstitut National de la Sant~ et de la Recherche M6dicale. M. Freedman 
was supported by Howard Hughes Medical Institutes/National Institutes of Health Scholars Program. 
Received for publication  2 May  1995 and in revised  form 2 February  1996. 
References 
1.  Wyllie, A.H. 1995.  The genetic regulation ofapoptosis. Curt. 
Opin.  Genet. Dev. 5:97-104. 
2.  Hengartner,  M.O.,  and  H.R.  Horvitz.  1994.  ProgranLmed 
cell death in Caenorhabditis elegans. Curr. Opin.  Genet. Dev. 
4:581-586. 
2115  Combadibre et al. 
3.  Cohen, J.J.,  R.C. Duke, V.A. Fadok, and K.S. Sellins.  1992. 
Apoptosis and cell death in immunity. Annu.  Rev.  Immunol. 
10:267-293. 
4.  Green,  D.R.,  R.P.  Bissonnette, J.M.  Glynn,  and  Y.  Shi. 
1992.  Activation-induced  apoptosis  in  lymphoid  systems. Sem. Immunol. 4:379-388. 
5.  Critchfield, M.J., S.A. Boehme, and M.J. Lenardo. 1995. The 
regulation of antigen-induced apoptosis in mature T lympho- 
cytes. In Apoptosis and the Immune Response. C. Gregory, 
editor. Wiley-Liss, Inc., New York. 55-114. 
6.  Smith,  C.A.,  G.T.  Williams, R.  Kingston,  E.J.  Jenkinson, 
and J.J.T.  Owen.  1989.  Antibodies to CD3/T-cell receptor 
complex induce  death by apoptosis in immature T  cells in 
thymic cultures. Nature (Lond.). 337:181-184. 
7.  Murphy, K.M., A.B. Heimberger, and D.Y. Loh.  1990.  In- 
duction by antigen of intrathymic apoptosis of CD4+CD8 + 
TCR  l~ thymocytes in vivo. Science (Wash.  DC).  250:1720- 
1723. 
8.  Allen, P.M. 1994. Peptides in positive and negative selection: 
a delicate balance. Cell. 76:593-596. 
9.  Lenardo,  M.J.  1991.  Interleukin-2  programs  mouse  alpha 
beta T  lymphocytes for apoptosis. Nature  (Lond.). 353:858- 
861. 
10. Russell, J.H., C.L. White, D.Y. Loh, and P. Melleedy-Rey. 
1991.  Receptor-stimulated death pathway is opened by anti- 
gen in mature T  cells. Proc. Natl. Acad. Sci. USA.  88:2151- 
2157. 
11. Critchfield, J.M., J.C.  Zuniga-Pflucker, and  M.J.  Lenardo. 
1995.  Parameters controlling apoptosis in high dose suppres- 
sion of mature T lymphocytes. Cell. Immunol.  160:71-78. 
12. Singer, G.G., and A.K. Abbas. 1994.  The Fas antigen is in- 
volved in peripheral but not thymic deletion of T  lympho- 
cytes in T  cell receptor transgenic mice.  Immunity.  1:365- 
373. 
13. Clevers, H., B. Alarcon, T. Wileman, and C. Terhorst. 1988. 
The T  cell receptor/CD3  complex: a dynamic protein en- 
semble. Annu. Rev. Immunol. 6:629-662. 
14. Ashwell, J.D., and R.D.  Klausner.  1990.  Genetic and muta- 
tional analysis of the T-cell antigen receptor. Annu.  Rev. Im- 
munol. 8:139-167. 
15. Reth,  M.  1989.  Antigen receptor tail clue.  Nature  (Lond.). 
338:383-384. 
16. Samelson, L.E., and R.D.  Klausner.  1992.  Tyrosine kinases 
and  tyrosine-based activation  motifs. J.  Biol. Chem.  267: 
24913-24916. 
17. Cambier, J.C.  1995.  New nomenclature for the Reth motif 
(or  ARH1/TAM/ARAM/YXXL).  Immunology Today. 16: 
110. 
18. Cooke, M.P., K.M. Abraham, K.A. Forbush, and R.M. Perl- 
mutter.  1991.  Regulation of T  cell receptor signaling by src 
family protein tyrosine kinase p56  fyn. Cell. 65:281-291. 
19. Glaischenhaus,  N., N. Shastri, D.R. Littman, andJ.M. Turner. 
1991. Requirement for association of p561ok with CD4 in an- 
tigen-specific signal transduction in T cells. Cell. 64:511-520. 
20. Samelson, L.E., A.F. Phihps, E.T. Luong, and R.D. Klausner. 
1990.  Association of thefyn protein-tyrosine kinase with the 
T  cell antigen receptor. Proc. Natl.  Acad. Sci. USA. 87:4358- 
4362. 
21.  Straus, D., and A. Weiss. 1992.  Genetic evidence for involve- 
ment of lck tyrosine kinase in signal transduction through the 
T cell antigen receptor. Cell. 70:585-593. 
22. Songyang,  Z.,  S.E.  Shoelson,  M.  Chaudhuri,  G.  Gish,  T. 
Pawson,  W.G.  Haser,  F.  King,  T.  Roberts,  S.  Ratnofsky, 
R.J. Lechleider et al.  1993.  SH2 domains recognize specific 
phosphopeptide sequences. Cell. 72:767-778. 
23. Songyang,  Z.,  S.E.  Shoelson, J.  McGlade,  P.  Olivier,  T. 
Pawson, X.R. Bustelo, M. Barbacid, H. Sabe, H. Hanafusa, 
T. Yi et al. 1994.  Specific moti~ recognized by SH2 domains 
of Csk,  3BP2,  fps/fes, GRB-2,  HCP,  SHC,  Syk, and Vav. 
Mol.  Cell. Biol. 14:2777-2785. 
24. Isakov, N., R.L. Wange, W.H. Burgess, .I,D. Watts, R. Ae- 
bersold, and L.E. Samelson. 1995.  ZAP-70 binding specific- 
ity to  T  cell receptor tyrosine-based activation motifs: the 
tandem SH2 domains of ZAP-70 bind distinct tyrosine--based 
activation motis  with varying affinity.J. Exp. Med.  181:375- 
380. 
25. Frank,  S.J.,  C.  Cenciarelli, B.B.  Niklinski,  F.  Letourneur, 
J.D. Ashwell, and A.M. Weissman.  1992.  Mutagenesis of T 
cell antigen receptor ~ chain tyrosine residues. J.  Biol. Chem. 
267:13656-13660. 
26. Irving,  B.A.,  A.C.  Chan,  and  A.  Weiss.  1993.  Functional 
characterization of a signal transducing motif present in the T 
cell antigen receptor { chain.J. Exp, Med.  177:1093-1103. 
27. Donnadieu,  E.,  A.  Trautmann,  M.  Malissen, J.  Trucy,  B. 
Malissen, and E. Vivier. 1994. Reconstitution of CD3{ cou- 
pling to calcium mobilization via genetic complementation. 
J. Biol. Chem.  269:32828-32834. 
28. Irving, B.A., and A. Weiss. 1991. The cytoplasmic domain of 
the T cell receptor ~ chain is sufficient to couple to receptor- 
associated signal transduction pathways. Cell. 64:891-901. 
29. Letourneur,  F.,  and R.D.  Klausner.  1992.  Activation of T 
cells by a tyrosine kinase activation domain in the cytoplasmic 
tail of CD3e. Science (Wash. DC). 255:79-82. 
30. Romeo,  C.,  M.  Amiot,  and B.  Seed.  1992.  Sequence  re- 
quirements for induction of cytolysis by the T cell antigen/Fc 
receptor zeta chain. Cell. 68:889-897. 
31. Weiss, A., and D.R.  Littman.  1994.  Signal transduction by 
lymphocyte antigen receptors. Cell. 76:263-274. 
32.  Shinkai, Y., A. Ma, H.  Cheng,  and F.W. Alt. 1995.  CD3~ 
and CD3~  cytoplasmic domains can independently generate 
signals  for  T  cell development and  function.  Immunity.  2: 
401-411. 
33. Wegener, A.-M.K., F. Letourneur, A. Hoeveler, T. Brocker, 
F. Luton, and B. Malissen. 1992.  The T  cell receptor/CD3 
complex is composed of at least two autonomous transduc- 
tion modules. Cell. 68:83-95. 
34. Hermans, M.H.A., and B.  Mahssen.  1993.  The cytoplasmic 
tail of the T  cell receptor ~ chain is dispensable for antigen- 
mediated T  cell activation. Eur. J. Immunol. 23:2257-2262. 
35. Vignaux, F., E. Vivier, B, Malissen, V. Depraetere, S. Nagata, 
and P. Golstein. 1995.  TCR/CD3 coupling to Fas-based cy- 
totoxicity.J. Exp. Med.  181:781-786. 
36. Higuchi, R., B. Krummel, and R.K. Saiki. 1988.  A  general 
method  of in vitro preparation and specific mutagenesis of 
DNA fragments: study of protein and DNA interactions. Nu- 
cleic Acids Res.  16:7351-7367. 
37. Takebe, Y.,  M.  Seiki, J.  Fujisawa, P.  Hoy, K.  Yokota,  K. 
Arai, M. Yoshida, and N. Arai. 1988.  SR alpha promoter: an 
efficient and versatile mammalian cDNA expression system 
composed  of the  simian  virus  40  early promoter  and  the 
R-U5 segment of human T-cell leukemia virus type 1 long. 
Mol.  Cell. Biol. 8:466-472. 
38. Love, P.E., E.W. Shores, M.D. Johnson, M.L. Temblay, E.,I. 
Lee, A. Grinberg, S.P. Huang, A. Singer, and H. Westphal. 
1993. T  cell development in mice that lack the ~ chain of the 
T  cell antigen receptor complex. Science (Wash.  DC).  261: 
918-921. 
39.  Shores, E.W., K. Huang, T. Tran, R. Lee, A. Grinberg, and 
P.E.  Love.  1994.  Role of TCR-~  chain in T  cell develop- 
ment and selection. Science (Wash.  DC). 266:1047-1050. 
40. Boehme, S.A., and M.J. Lenardo. 1993.  Propriocidal apopto- 
2116  TCR-~ Chain Facilitates Mature T Cell Death sis of mature T lymphocytes occurs at S phase of the cell cy- 
cle. Eur.J.  Immunol. 23:1552-1560. 
41. Leo, O., M. Foo, D.H. Sachs, L.E. Samelson, andJ.A. Blue- 
stone. 1987.  Identification of a monoclonal antibody specific 
for murine T3  polypeptide. Proc. Natl.  Acad.  Sci.  USA.  84: 
1374-1379. 
42. Oh-Ishi, R.T.,  C.K.  Goldman, and T.A. Waldmann.  1989. 
The interaction ofinterleukin-2 with its receptor in the gen- 
eration of suppressor T  cells in antigen specific and antigen- 
nonspecific system in vitro. Clin.  Immunol.  Immunopathol.  52: 
447-459. 
43. Boehme, S.A., and M.J. Lenardo. 1993. Ligand-induced apop- 
44. 
45. 
tosis of mature T  lymphocytes (propriocidal regulation) oc- 
curs at distinct stages of the cell cycle. Leukemia (Baltimore).  7: 
$45-$49. 
Sussman,  J.J., J.S. Bonifacino, J.  Lippincott-Schwartz, A.M. 
Weissman, T. Saito, R..D. Klausner, andJ.D. Ashwell. 1988. 
Failure to synthesize the T cell CD3-zeta chain: structure and 
function of a partial T cell receptor complex. Cell. 52:85-95. 
Lenardo,  M.J.,  S.  Boehme,  L.  Chen,  B.  Combadiere,  G. 
Fisher,  M.  Freedman,  H.  McFarland,  C.  Pelfrey,  and  L. 
Zheng. 1995. Autocrine feedback death and the regulation of 
mature T  lymphocyte antigen responses. Int.  Rev.  Immunol. 
13:115-134. 
2117  Combadi~re et al. 